Custom Antibody Market Research Report – Forecast till 2027

Custom Antibody Market: By Service (Antibody Development), Source (Mice, Others), Research Area (Oncology, Neurobiology), Type (Monoclonal Antibodies, Polyclonal Antibodies), End Users (Biotechnology Companies) — Forecast till 2027

ID: MRFR/HC/5597-HCR | February 2021 | Region: Global | 85 pages

Custom Antibody Market Scenario:
The Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023).


Custom antibody provides high specificity and selectivity, these antibodies are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Factors such as increasing research activity in life sciences industry along with increasing associations between industry and academic centers is driving the growth of the custom antibody market. The advantage of custom antibody is that it accomplishes well in a qualitative or quantitative immunodetection method. The quality of catalog antibodies is also an area of concern in this market, and henceforth end users prefer custom-made antibodies.


Segmentation:
The Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.


On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production.


On the basis of source, the market has been classified as mice, rabbits, human beings and others.


On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others.


On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas


On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European custom antibody market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The custom antibody market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The custom antibody market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Custom Antibody Market Share, by Region, 2017 (%)


Source: MRFR Analysis


In the custom antibody market, North America is anticipated to account for largest market share due to the early adoption of advanced medical technologies, continuous development by companies operating into disease treatment. The largest market share is credited to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.
The European market is expected to hold the second largest market share. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.


Whereas the Asia-Pacific region is projected to be the fastest growing segment experience in the near future due to the growing therapeutic industry in India and China, also the increasing funds in life science research by the government organizations of these countries are aspects driving the growth of the Asia-Pacific market. Similarly, the increasing research in genomics and proteomics, growing investments by pharmaceutical companies, rising awareness about personalized therapeutics, and growing research activities in the field of mAb-based therapeutics are boosting the growth of this custom antibody market in Asia-Pacific region.


The market in the Middle East & Africa is expected to account for the smallest share of the global custom antibody market due to an underdeveloped healthcare sector, the dearth of technical knowledge, and poor medical facilities.


Key Players:
Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.


Custom Antibody Market, by Service:



  • Antibody Development

    • Antibody Characterization

    • Antigen Preparation

    • Immunization & Hybridoma Production



  • Antibody Production & Purification

  • Antibody Fragmentation & Labeling


Custom Antibody Market, by Source:



  • Mice

  • Rabbits

  • Human Beings

  • Others


Custom Antibody Market, by Type:



  • Monoclonal Antibodies

  • Polyclonal Antibodies

  • Recombinant Antibodies

  • Other Custom Antibodies


Custom Antibody Market, by Research Area:



  • Oncology

  • Infectious Diseases

  • Immunology

  • Neurobiology

  • Stem Cells

  • Cardiovascular Diseases

  • Others


Custom Antibody Market, by End-Users:



  • Hospitals and Clinics

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations


Custom Antibody Market, by Region:



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Company Profiles:



  • Thermo Fisher Scientific Inc.

  • Genscript

  • Abcam PLC

  • Merck Group

  • Bio-Rad Laboratories, Inc.

  • Cell Signaling Technology, Inc.

  • Agilent Technologies, Inc.

  • Biolegend, Inc.

  • Rockland Immunochemicals Inc.

  • Promab Biotechnologies, Inc.

  • Proteogenix

  • Innovagen Ab


Intended Audience:



  • Manufacturers and distributors

  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

  • Research institutes

  • Contract manufacturing organizations (CMOs)

  • Government associations

  • Market research and consulting firms

  • Venture capitalists and investors


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9.6% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Service, Source, Type, Research area and End users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing research activity in life sciences industry
  • Increasing associations between industry and academic centers


  • Speak to Analyst Ask for Customization

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Custom Antibody Market, by Service

    6.1 Introduction

    6.2 Antibody Development

    6.2.1 Antibody Characterization

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.2 Antigen Preparation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.2.3 Immunization & Hybridoma Production

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Antibody Production & Purification

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Antibody Fragmentation & Labeling

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Custom Antibody Market, by Source

    7.1 Introduction

    7.2 Mice

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Rabbits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Human beings

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Other Sources

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Custom Antibody Market, by Type

    8.1 Introduction

    8.2 Monoclonal Antibodies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Polyclonal Antibodies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Recombinant Antibodies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Other Custom Antibodies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Custom Antibody Market, by Research Area

    9.1 Introduction

    9.2 Oncology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Infectious Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Immunology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.5 Neurobiology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.6 Stem Cells

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.7 Cardiovascular Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.8 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Custom Antibody Market, by End-Users

    10.1 Introduction

    10.2 Pharmaceutical & Biotechnology Companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.3 Hospitals and Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.4 Academic & Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.5 Contract Research Organizations

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.6 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027


    Chapter 11. Global Custom Antibody Market, by Region

    11.1 Introduction

    11.2 Americas

    11.2.1 North America

    11.2.1.1 US

    11.2.1.2 Canada

    11.2.2 South America

    11.3 Europe

    11.3.1 Western Europe

    11.3.1.1 Germany

    11.3.1.2 France

    11.3.1.3 Italy

    11.3.1.4 Spain

    11.3.1.5 UK

    11.3.1.6 Rest of Western Europe

    11.3.2 Eastern Europe

    11.4 Asia-Pacific

    11.4.1 Japan

    11.4.2 China

    11.4.3 India

    11.4.4 Australia

    11.4.5 South Korea

    11.4.6 Rest of Asia-Pacific

    11.5 Middle East & Africa

    11.5.1 Middle East

    11.5.2 Africa

    Chapter 12. Company Landscape

    12.1 Introduction

    12.2 Market Share Analysis

    12.3 Key Development & Strategies

    Chapter 13. Company Profiles

    13.1 Thermo Fisher Scientific Inc.

    13.1.1 Company Overview

    13.1.2 Product Overview

    13.1.3 Financials Overview

    13.1.4 Key Developments

    13.1.5 SWOT Analysis

    13.2 Genscript

    13.2.1 Company Overview

    13.2.2 Product Overview

    13.2.3 Financial Overview

    12.2.4 Key Developments

    13.2.5 SWOT Analysis

    13.3 Abcam PLC

    13.3.1 Company Overview

    13.3.2 Product Overview

    13.3.3 Financial Overview

    13.3.4 Key Development

    13.3.5 SWOT Analysis

    13.4 Merck Group

    13.4.1 Company Overview

    13.4.2 Technology/Business Segment Overview

    13.4.3 Financial Overview

    13.4.4 Key Development

    13.4.5 SWOT Analysis

    13.5 Bio-Rad Laboratories, Inc.

    13.5.1 Company Overview

    13.5.2 Product Overview

    13.5.3 Financial overview

    13.5.4 Key Developments

    13.5.5 SWOT Analysis

    13.6 Cell Signaling Technology, Inc.

    13.6.1 Company Overview

    13.6.2 Product Overview

    13.6.3 Financial Overview

    13.6.4 Key Developments

    13.6.5 SWOT Analysis

    13.7 Agilent Technologies, Inc.

    13.7.1 Overview

    13.7.2 Product Overview

    13.7.3 Financial Overview

    13.7.4 Key Developments

    13.7.5 SWOT Analysis

    13.8 Biolegend, Inc.

    13.8.1 Overview

    13.8.2 Service / Technology Overview

    13.8.3 Financials

    13.8.4 Key Developments

    13.8.5 SWOT Analysis

    13.9 Rockland Immunochemicals Inc.

    13.9.1 Overview

    13.9.2 Product Overview

    13.9.3 Financials

    13.9.4 Key Developments

    13.9.5 SWOT Analysis

    13.10 Promab Biotechnologies, Inc.

    13.10.1 Overview

    13.10.2 Product Overview

    13.10.3 Financials

    13.10.4 Key Developments

    13.10.5 SWOT Analysis

    13.11 Proteogenix

    13.11.1 Overview

    13.11.2 Product Overview

    13.11.3 Financials

    13.11.4 Key Developments

    13.11.5 SWOT Analysis

    13.12 Innovagen Ab

    13.12.1 Overview

    13.12.2 Product Overview

    13.12.3 Financials

    13.12.4 Key Developments

    13.12.5 SWOT Analysis

    Chapter 14 MRFR Conclusion

    14.1 Key Findings

    14.1.1 From CEO’s Viewpoint

    14.1.2 Unmet Needs of the Market

    14.2 Key Companies to Watch

    14.3 Predictions for the Custom Antibody Industry

    Chapter 15. Appendix

    LIST OF TABLES

    Table 1 Global Custom Antibody Market Synopsis, 2020-2027

    Table 2 Global Custom Antibody Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Custom Antibody Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 5 Global Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 6 Global Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 7 Global Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 8 Global Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 9 North America: Custom Antibody Market, by Service, 2020-2027 (USD

    Million)

    Table 10 North America: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 11 North America: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 12 North America Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 13 North America: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 14 US: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 15 US: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 16 US: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 17 US: Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 18 US: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 19 Canada: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 20 Canada: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 21 Canada: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 22 Canada Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 23 Canada: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 24 South America: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 25 South America: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 26 South America: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 27 South America Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 28 South America: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 29 Europe: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 30 Europe: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 31 Europe: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 32 Europe Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 33 Europe: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 34 Western Europe: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 35 Western Europe: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 36 Western Europe: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 37 Western Europe Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 38 Western Europe: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 39 Eastern Europe: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 40 Eastern Europe Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 41 Eastern Europe Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 42 Eastern Europe Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 43 Eastern Europe: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 44 Asia-Pacific: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 45 Asia-Pacific: Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 46 Asia-Pacific: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 47 Asia-Pacific Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 48 Asia-Pacific: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Table 49 Middle East & Africa: Custom Antibody Market, by Service, 2020-2027 (USD Million)

    Table 50 Middle East & Africa Custom Antibody Market, by Source, 2020-2027 (USD Million)

    Table 51 Middle East & Africa: Custom Antibody Market, by Type, 2020-2027 (USD Million)

    Table 52 Middle East & Africa Custom Antibody Market, by Research Area, 2020-2027 (USD Million)

    Table 53 Middle East & Africa: Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Custom Antibody Market

    Figure 3 Segmentation Market Dynamics for Global Custom Antibody Market

    Figure 4 Global Custom Antibody Market Share, by Service, 2020

    Figure 5 Global Custom Antibody Market Share, by Source, 2020

    Figure 6 Global Custom Antibody Market Share, by Type, 2020

    Figure 7 Global Custom Antibody Market Share, by Research Area, 2020

    Figure 8 Global Custom Antibody Market, by End-users, 2020-2027 (USD Million)

    Figure 9 Global Custom Antibody Market Share, by Region, 2020

    Figure 10 North America: Custom Antibody Market Share, by Country, 2020

    Figure 11 Europe: Custom Antibody Market Share, by Country, 2020

    Figure 12 Asia-Pacific: Custom Antibody Market Share, by Country, 2020

    Figure 13 Middle East & Africa: Custom Antibody Market Share, by Country, 2020

    Figure 14 Global Custom Antibody Market: Company Share Analysis, 2020 (%)

    Figure 15 Thermo Fisher Scientific Inc.: Key Financials

    Figure 16 Thermo Fisher Scientific Inc.: Segmental Revenue

    Figure 17 Thermo Fisher Scientific Inc.: Geographical Revenue

    Figure 18 Genscript: Key Financials

    Figure 19 Genscript: Segmental Revenue

    Figure 20 Genscript: Geographical Revenue

    Figure 21 Abcam PLC: Key Financials

    Figure 22 Abcam PLC: Segmental Revenue

    Figure 23 Abcam PLC: Geographical Revenue

    Figure 24 Merck Group: Key Financials

    Figure 25 Merck Group: Segmental Revenue

    Figure 26 Merck Group: Geographical Revenue

    Figure 27 Bio-Rad Laboratories, Inc.: Key Financials

    Figure 28 Bio-Rad Laboratories, Inc.: Segmental Revenue

    Figure 29 Bio-Rad Laboratories, Inc.: Geographical Revenue

    Figure 30 Cell Signaling Technology, Inc.: Key Financials

    Figure 31 Cell Signaling Technology, Inc.: Segmental Revenue

    Figure 32 Cell Signaling Technology, Inc.: Geographical Revenue

    Figure 33 Agilent Technologies, Inc.: Key Financials

    Figure 34 Agilent Technologies, Inc.: Segmental Revenue

    Figure 35 Agilent Technologies, Inc.: Geographical Revenue

    Figure 36 Biolegend, Inc.: Key Financials

    Figure 37 Biolegend, Inc.: Segmental Revenue

    Figure 38 Biolegend, Inc.: Geographical Revenue

    Figure 39 Rockland Immunochemicals Inc.: Key Financials

    Figure 40 Rockland Immunochemicals Inc.: Segmental Revenue

    Figure 41 Rockland Immunochemicals Inc.: Geographical Revenue

    Figure 42 Promab Biotechnologies, Inc.: Key Financials

    Figure 43 Promab Biotechnologies, Inc.: Segmental Revenue

    Figure 44 Promab Biotechnologies, Inc.: Geographical Revenue

    Figure 45 Proteogenix: Key Financials

    Figure 46 Proteogenix: Segmental Revenue

    Figure 47 Proteogenix: Geographical Revenue

    Figure 48 Innovagen Ab: Key Financials

    Figure 49 Innovagen Ab: Segmental Revenue

    Figure 50 Innovagen Ab: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.